Search

everythinglearnresearchcommunity

for

Search:↓

The research showed how melanocytes develop, move, and respond to UV light, and their stem cells' role in hair color and skin cancer risk.

The type of tumor suppressor affects the form of skin cancer from hair follicle stem cells.

Cells with active Wnt signaling are less likely to turn into cancer when exposed to a cancer-causing gene.

Overexpressing Merkel cell virus proteins in human hair follicles can create clusters of cells that resemble Merkel cell cancer.

Different types of skin cells have unique genetic markers that affect how likely they are to spread cancer.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

Certain proteins, Lgr5 and Lgr6, are important markers of adult stem cells and are involved in tissue repair and cancer development.

Biomedical imaging has greatly improved understanding and treatment of solid tumors.

Benign tumors from hair follicles can look like other skin cancers but have distinct features under dermoscopy.

Melanocytic matricoma can look like skin cancer but is usually harmless; surgery and follow-up are advised.

Understanding factors affecting recurrence and survival can improve treatment for head and neck skin cancer.

Hair follicle stem cells may cause squamous cell carcinoma due to a metabolic shift towards glycolysis.

Giant solitary trichoepithelioma is a rare, usually non-cancerous hair follicle tumor that can sometimes turn into skin cancer.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

Cox-2 significantly contributes to the development and progression of skin and esophageal cancers.

Deleting the Trf1 protein in mice is safe and may help prevent cancer without major side effects.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Skin and hair can regenerate after injury due to changes in gene activity, with potential links to how cancer spreads. Future research should focus on how new hair follicles form and the processes that trigger their creation.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

In vivo lineage labelling is better than in vitro methods for identifying and understanding stem cells.

Mesenchymal stromal cell therapies show promise for treating various diseases but need more research and standardization.

Some skin tumors may start from hair follicle stem cells.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Recognizing specific markers is crucial for correctly diagnosing and treating rare multifocal MPTT in males.

The document concludes that recent studies help tell apart desmoplastic trichoepitheliomas from other skin tumors, but more research is needed for clear differentiation.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

A stable, active version of a growth factor was made in bacteria, showing promise for medical use.

Hair growth and pigmentation in mice involve specific stages crucial for research.